HTN1 and cancer: We hypothesized that the anticancer effect of bi-TPB-PPB antibodies will become more pronounced when cancer cells are sensitized, for example, by treatment with disulfiram (DSF), a known ALDH2 inhibitor and promising adjuvant for anticancer therapy28.